Global Hypercalcemia Treatment Market 2017-2021

Overview of the global hypercalcemia treatment market

Based on the hypercalcemia treatment market analysis, the global hypercalcemia treatment market is expected to grow at a steady rate and post a CAGR of more than 5% during the forecast period. The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.

The growing preference for combination therapy will drive the prospects for the global hypercalcemia treatment market growth until the end of 2021. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.

Competitive landscape and key vendors

The global hypercalcemia treatment market is fragmented and is characterized by the presence of various local, regional, and international vendors. The growing rate of endocrine disorders such as hyperparathyroidism and kidney diseases will propel the demand for the production of drugs. The vendors in the market are increasingly competing against each other based on factors such as aggressive pricing and new indications. To penetrate further into the hyperparathyroidism market, several vendors are focusing on conducting extensive research and developmental activities and gain approvals. Furthermore, a large number of market players are also increasingly developing effective treatments for spasticity due to the high unmet medical needs.

Key vendors in this market are -

• AbbVie
• Amgen
• Merck
• Novartis
• OPKO Health

Other prominent vendors in the market include DiaSorin, Rockwell Medical, Kyowa Hakko Kirin, and Fujirebio.

Segmentation by product type and analysis of the hypercalcemia treatment market

• Bisphosphonates
• Glucocorticoids
• Calcimimetic agents

The bisphosphonates segment dominated the global hypercalcemia treatment market during 2016 and is likely to experience a high growth rate during the estimated period. The dominant position of this segment is mainly due to the growing demand for preventive treatment of hypercalcemia, the availability of a wide range of bisphosphonates, established clinical evidence, and the increasing number of disorders such as resistant hypercalcemia or heterotopic calcification.

Segmentation by geography and analysis of the hypercalcemia treatment market

• Americas
• APAC
• EMEA

The Americas was the largest revenue contributor that accounted for a significant portion of the market shares during 2016 and is estimated to dominate the market in the forthcoming years as well. Factors such as the growing incidence of hyperparathyroidism and kidney disease, expanding label indications, the increasing competition from generic players, and the growing focus of vendors in developing novel drugs, will drive the market’s growth in this region.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global hypercalcemia treatment market?
• What are the key market trends impacting the growth of the global hypercalcemia treatment market?
• What are the challenges to market growth?
• Who are the key vendors in the global hypercalcemia treatment market?
• What are the market opportunities and threats faced by the vendors in the global hypercalcemia treatment market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global hypercalcemia treatment market?

Technavio also offers customization on reports based on specific client requirement.